We're aware that the Therapeutic Products Bill, which we will be introducing at the earliest possible opportunity, will be addressing the issues found in this bill and more. But we strongly felt that it was important to support this bill because it would provide immediate and a little bit more timely cover. But the Therapeutic Products Bill will address other issues such as accredited laboratories and how often testing should happen. But, in the meantime, we welcome this bill.